After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

Banks are pitching around €1 billion ($1.05 billion) in debt packages to back a potential buyout of Karo Healthcare, according to people familiar with the matter.

It marks a significant change in direction for Ipsen, which has spent several years of building up the consumer health business through the acquisition of products from Sanofi, Boehringer ...

The Jury Chair for the 11th edition of IMA is Sudhir Sitapati, Managing Director & CEO, Godrej Consumer Products ...

The third new business unit – emerging markets – bundles Sanofi's generic medicines and older products still in patent with the company's consumer ... and animal health products divisions ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an ...

Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...

Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...